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PURPOSE: To assess the usefulness of a second biopsy when the first one was
inconclusive in patients with a liver nodule found during the follow-up for chronic liver
disease.
MATERIALS AND METHODS: Among 381 patients (544 nodules) included in a
prospective study designed to evaluate the accuracy of imaging for the diagnosis of
small hepatocellular carcinoma (HCC) in chronic liver disease, 254 nodules were
biopsied. The following histological results were considered as conclusive: HCC,
dysplastic or regenerative nodule, and other identified tumors (benign or malignant).
For nodules with inconclusive results (e.g. fibrosis or no definite focal lesion), a
second biopsy was suggested, but was not mandatory.
RESULTS: A total of 242 patients (194 men, 48 women; mean age, 61.9±9.5 [SD];
range: 40.2-89.0years) with 254 nodules underwent a first biopsy. Mean nodule
diameter was 19.2±5.4mm (range: 10-33mm). The first biopsy was conclusive in
189/254 nodules (74.4%): 157 HCCs (83.1%), 11 regenerative nodules (5.8%), 10
dysplastic nodules (5.3%), 3 cholangiocarcinomas (1.6%), and 8 other tumors (4.2%).
Among the 65 nodules for which the first biopsy was inconclusive, a second biopsy was
performed for 17 nodules in 16 patients within 6 months of the first one. It was
conclusive in 13/17 nodules (76.5%): 10 HCCs (76.9%), 2 dysplastic nodules (15.4%),
and 1 other tumor (7.7%). In 4/17 nodules (23.5%), no definitive diagnosis could be
provided.
CONCLUSION: The diagnostic yield of a second biopsy of a suspicious lesion
suggestive of HCC in chronic liver disease is not decreased compared to the first one.
Repeated biopsy after a first negative one could be an alternative option to the follow-
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